APA (7th ed.) Citation

O, C., & O, D. (2026). Neoadjuvant nivolumab plus chemotherapy in resectable NSCLC: A pharmacological outcome study. Pakistan journal of pharmaceutical sciences, 39(8), 2535. https://doi.org/10.36721/PJPS.2026.39.8.238.1

Chicago Style (17th ed.) Citation

O, Can, and Derdiyok O. "Neoadjuvant Nivolumab Plus Chemotherapy in Resectable NSCLC: A Pharmacological Outcome Study." Pakistan Journal of Pharmaceutical Sciences 39, no. 8 (2026): 2535. https://doi.org/10.36721/PJPS.2026.39.8.238.1.

MLA (9th ed.) Citation

O, Can, and Derdiyok O. "Neoadjuvant Nivolumab Plus Chemotherapy in Resectable NSCLC: A Pharmacological Outcome Study." Pakistan Journal of Pharmaceutical Sciences, vol. 39, no. 8, 2026, p. 2535, https://doi.org/10.36721/PJPS.2026.39.8.238.1.